Skip to search formSkip to main contentSkip to account menu

tobanum

Known as: CLORANOLOL, chloranolol, 2-propanol, 1-(2,5-dichlorophenoxy)-3-((1,1-dimethylethyl)amino)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryThe incidence of side-effects on administration of chloranolol (Tobanum®), a beta-adrenergic receptor blocking drug, to… 
1993
1993
Effectiveness of some physical therapeutic factors (constant magnetic field, impulse currents) and new hypotensive drugs (tobanum… 
1989
1989
Three nonselective beta-adrenoceptor blockers, propranolol, cloranolol and talinolol, were examined in male rats. The amount and… 
1985
1985
In a single blind clinical trial the effects of Tobanum (chloranolol), a beta-adrenergic receptor blocker, on 450 patients were… 
1980
1980
The acute and chronic circulatory effects of a new beta adrenergic blocking drug, dl-1-(2,5-dichlorophenoxy)-3-tertiary… 
1980
1980
1980
  • F. Solti, E. Czakó
  • International journal of clinical pharmacology…
  • 1980
  • Corpus ID: 20572929
The electrophysiological properties of Tobanum (a new beta receptor blocking drug) were studied in 14 patients by the aid of His…